News

January 18, 2013

OBI’s company English name official renamed OBI Pharma, Inc.

August 8, 2012

Breast Cancer New Drug: OBI-822/821 received Taiwan FDA Approval for entering Phase III trial

[…]
July 20, 2012

DIFICID (Fidaxomicin) Approved by Taiwan Department of Health for the Treatment of CDAD

[…]